Werdegang
| Since 11/2020 | Professor of Oncology, University of Zurich Vice Chairman, Dept. of Oncology & Hematology, University Hospital Zurich Director, Comprehensive Cancer Center Zurich (CCCZ), Clinical Program |
|---|---|
| 05/18-02/21 | Head of Oncology, Hematology & Immunotherapy Cantonal Hospital Baselland, sites of Liestal, Bruderholz and Laufen Co-Chair, Personalized Health Basel (PHB) Oncology Cluster, University of Basel (together with M. Bentires-Alj) |
| 12/16-04/18 | Senior Consultant (Leitender Arzt) and Head of Phase 1 Oncology Unit, Dept. of Oncology, University Hospital Basel (Prof. Ch. Rochlitz) Co-head Network for Molecular Tumor Therapy, Cancer Center, University Hospital Basel Co-Chair, Personalized Health Basel (PHB) Oncology Cluster, University of Basel (together with M. Bentires-Alj) |
| 2016 | Habilitation (venia docendi for oncology), University of Basel |
| 07/11-11/16 | Consultant (Oberarzt) and Head of Phase 1 Oncology Unit, Dept. of Oncology, University Hospital Basel (Prof. Ch. Rochlitz) Project leader, Lab of Medical Oncology, Dept. of Biomedicine, University of Basel |
| 01/11-06/11 | Fellow, Dept. of Oncology and Dept. of Biomedicine, University and University Hospital, Basel (Prof. R. Herrmann) |
| 04/10-12/10 | Fellow, Albert-Ludwigs University, Freiburg im Breisgau (Dept. of Hematology and Oncology, allogeneic HSC transplant unit; Prof. J. Finke) |
| 07/07-03/10 | Resident, Dept. of Internal Medicine, University Hospital Basel (including emergency department and intensive care unit, Prof. J. A. Schifferli) Resident, Dept. of Oncology, University Hospital Basel (Prof. R. Herrmann) |
| 2007 | Ph.D. degree (summa cum laude), Faculty of Science, University of Basel |
| 07/04- 06/07 | MD-PhD Fellow of the Swiss Academy of Medical Sciences and the Swiss National Science Foundation, Laboratory of Tumor Biology, Institute of Biochemistry and Genetics, University of Basel (Prof. G. Christofori) |
| 06/03-06/04 | Resident in Internal Medicine, District Hospital, Rheinfelden (Dr. H.U. Iselin) |
Wichtigste Mitgliedschaften
- American Association for Cancer Research (AACR)
- European Society for Medical Oncology (ESMO)
- Swiss Medical Association (FMH)
- Swiss Society of General Internal Medicine (SGAIM, formerly SGIM)
- Swiss Society of Medical Oncology (SGMO)
- Swiss MD-PhD Association (SMPA)
Forschungsschwerpunkte
- Prediction of therapy based on clinical and biological data (personalized oncology)
- Early clinical trials
- Mechanisms of tumour invasion
Publikationen
Publikationsliste anzeigenWeiteres
Awards:
- Contest of the Swiss Foundation for Young Scientists, 3rd prize 1995
- Roche Poster Award 2006 (Biovalley day)
- SAKK – Amgen Research Grant 2007 (together with C. Mamot)